Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies
Abstract Aims Since December 2019, the novel coronavirus SARS‐CoV‐2 has spread rapidly throughout China and keeps the world in suspense. Cardiovascular complications with myocarditis and embolism due to COVID‐19 have been reported. SARS‐CoV‐2 genome detection in the heart muscle has not been demonst...
Main Authors: | Felicitas Escher, Heiko Pietsch, Ganna Aleshcheva, Thomas Bock, Christian Baumeier, Albrecht Elsaesser, Philip Wenzel, Christian Hamm, Ralph Westenfeld, Maximilian Schultheiss, Ulrich Gross, Lars Morawietz, Heinz‐Peter Schultheiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12805 |
Similar Items
-
Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection
by: Heiko Pietsch, et al.
Published: (2021-01-01) -
How to perform an endomyocardial biopsy?
by: Carsten Tschöpe, et al.
Published: (2015-09-01) -
MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies
by: Ganna Aleshcheva, et al.
Published: (2021-02-01) -
THE ROLE OF ENDOMYOCARDIAL BIOPSY IN DIAGNOSTICS OF INFLAMMATORY MYOCARDIUM DISEASES
by: L. B. Mitrofanova
Published: (2016-01-01) -
Eosinophilia to endomyocardial fibrosis: Documentation of a case
by: Dinkar Bhasin, et al.
Published: (2018-01-01)